Pillstats
Rx only · Tablet, Film Coated · Oral

Leflunomide

Brands: Arava · Leflunomide

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US20 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)27169
US makers9 labelers
Packages30
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.096$0.192$0.288$0.384Dec 2025Apr 2026Jul 2026
$0.296
Latest avg · Jul 22, 2026
-11%
Since Dec 17, 2025
9
Active US suppliers
40%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

14K28K42K57K2025 Q12025 Q22025 Q32025 Q42026 Q1
43K
Rx · 2026 Q1
1.8M
Units dispensed
-3%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Zydus Lifesciences Limitedunknown6SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown6SUPPLYING
Bryant Ranch Prepackrepackager5SUPPLYING
Sanofi-Aventis U.S. LLCunknown3SUPPLYING
Burel Pharmaceuticals, LLCunknown2SUPPLYING
Lupin Pharmaceuticals,Inc.unknown2SUPPLYING
A-S Medication Solutionsunknown2SUPPLYING
NuCare Pharmaceuticals, Inc.unknown2SUPPLYING
Aurobindo Pharma Limitedunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jun 8, 2026
    RESOLVEDShortage resolved: Leflunomide Tablet (Sanofi-Aventis U.S. LLC)

    Leflunomide Tablet — reported in shortage by Sanofi-Aventis U.S. LLC. Therapeutic category: Rheumatology.

  • Jun 8, 2026
    SHORTAGEDrug shortage: Leflunomide Tablet (Sanofi-Aventis U.S. LLC)

    Leflunomide Tablet — reported in shortage by Sanofi-Aventis U.S. LLC. Therapeutic category: Rheumatology.